Rankings
▼
Calendar
CAMP Q3 2021 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$126M
Q3 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$79M
-5.4% YoY
Gross Profit
$33M
42.2% margin
Operating Income
-$998,000
-1.3% margin
Net Income
-$5M
-6.9% margin
EPS (Diluted)
$-0.15
QoQ Revenue Growth
-0.8%
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
$7M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$419M
Total Liabilities
$329M
Stockholders' Equity
$90M
Cash & Equivalents
$101M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$79M
$84M
-5.4%
Gross Profit
$33M
$31M
+8.3%
Operating Income
-$998,000
-$6M
+84.0%
Net Income
-$5M
-$9M
+42.8%
Revenue Segments
Product
$52M
65%
Application Subscriptions And Other Services
$27M
35%
Geographic Segments
U S
$54M
69%
E M E A
$13M
16%
South America
$8M
10%
Asia Pacific
$3M
4%
All Other
$1M
2%
← FY 2021
All Quarters
Q4 2021 →